W. Edward Fiets

1.0k total citations
16 papers, 206 citations indexed

About

W. Edward Fiets is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, W. Edward Fiets has authored 16 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in W. Edward Fiets's work include Breast Cancer Treatment Studies (7 papers), Head and Neck Cancer Studies (4 papers) and Estrogen and related hormone effects (3 papers). W. Edward Fiets is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Head and Neck Cancer Studies (4 papers) and Estrogen and related hormone effects (3 papers). W. Edward Fiets collaborates with scholars based in Netherlands, United Kingdom and Germany. W. Edward Fiets's co-authors include J.W.R. Nortier, H. Struikmans, Ingeborg van der Tweel, Gabriel Paardekooper, Geke A.P. Hospers, Karin Müller, Jannet C. Beukema, Christina T. Muijs, Johannes G. M. Burgerhof and Jan Willem de Groot and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

W. Edward Fiets

16 papers receiving 198 citations

Peers

Countries citing papers authored by W. Edward Fiets

Since Specialization

Citations

This map shows the geographic impact of W. Edward Fiets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Edward Fiets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Edward Fiets more than expected).

Fields of papers citing papers by W. Edward Fiets

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Edward Fiets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Edward Fiets. The network helps show where W. Edward Fiets may publish in the future.

Co-authorship network of co-authors of W. Edward Fiets

This figure shows the co-authorship network connecting the top 25 collaborators of W. Edward Fiets. A scholar is included among the top collaborators of W. Edward Fiets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Edward Fiets. W. Edward Fiets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Title	Journal	Authors	Indexed citations
1	Assessing the clinical benefit of systemic anti-cancer treatments in the Netherlands: The impact of different thresholds for effectiveness	European Journal of Cancer	B Leeneman, W. Edward Fiets et al.	1
2	Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not?	European Journal of Cancer	B Leeneman, Anne‐Marie C. Dingemans et al.	1
3	Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands	Frontiers in Oncology	W. Edward Fiets, Carin A. Uyl‐de Groot et al.	2
4	TGF-β and PD-L1 inhibition combined with definitive chemoradiotherapy in esophageal squamous cell carcinoma: A phase II clinical trial (NCT04595149).	Journal of Clinical Oncology	Maarten C.C.M. Hulshof, Connie R. Jiménez et al.	2
5	Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib‐randomized phase II study Commence	Head & Neck	Esther van Meerten, W. Edward Fiets et al.	12
6	Cost-effectiveness of prophylactic antibiotics to prevent pneumonia in patients treated with chemoradiotherapy (CRT) for locally advanced head and neck carcinoma (LAHNC).	Journal of Clinical Oncology	C.M.L. Driessen, Mathijs P. Hendriks et al.	1
7	Prophylactic antibiotics to prevent pneumonia in patients treated with chemoradiotherapy (CRT) for locally advanced head and neck carcinoma (LAHNC).	Journal of Clinical Oncology	C.M.L. Driessen, Mathijs P. Hendriks et al.	1
8	A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients	Annals of Oncology	Justin K. Smit, Christina T. Muijs et al.	87
9	Serum lactate dehydrogenase (LDH) as a prognostic selection criterion for ipilimumab treatment in metastatic melanoma.	Journal of Clinical Oncology	Christian U. Blank, Sander Kelderman et al.	2
10	The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer	Breast Cancer Research and Treatment	Remi A. Nout, W. Edward Fiets et al.	17
11	Prognostication and treatment decision-making in early breast cancer	Leiden Repository (Leiden University)	W. Edward Fiets	1
12	A multigene RT-PCR assay used to predict recurrence in early breast cancer: two presentations with contradictory results	Breast Cancer Research	W. Edward Fiets, J.W.R. Nortier	2
13	Prognostic value of mitotic counts in axillary node negative breast cancer patients with predominantly well-differentiated tumours	European Journal of Surgical Oncology	W. Edward Fiets, H. Struikmans et al.	6
14	Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients	European Journal of Cancer	W. Edward Fiets, J.W.R. Nortier et al.	66
15	The prognostic value of hormone receptor detection by enzyme immunoassay and immunohistochemistry: a prospective study in patients with early breast cancer	The International Journal of Biological Markers	W. Edward Fiets, Marinus A. Blankenstein et al.	4
16	The Prognostic Value of Hormone Receptor Detection by Enzyme Immunoassay and Immunohistochemistry: A Prospective Study in Patients with Early Breast Cancer	The International Journal of Biological Markers	W. Edward Fiets, Marinus A. Blankenstein et al.	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact